News
Un proyecto del IDIS desarrolla un modelo celular innovador para investigar la heteroplasia ósea progresiva
Se trata de una enfermedad ultrarrara de origen genético que provoca la formación gradual de hueso en tejidos donde no debería existir, como la piel o los músculos.
En el mundo solo existen 62 casos reportados de esta enfermedad causada por una mutación en el gen GNAS. En Galicia hay dos casos confirmados en gemelas.
Los premios Ennova Health 2025 reconocen la excelencia innovadora de dos proyectos del IDIS
El equipo FarmaCHUSLab, en colaboración con VARPA Group de la UDC, lidera PK-PDrugs, una plataforma dirigida a la posología personalizada de fármacos. El grupo GrHeCo-Gen desarrolla un proyecto de inteligencia artificial que facilita la toma de decisiones de los profesionales sanitarios en el diagnóstico y manejo de casos complejos
La investigadora Cintia Folgueira, Lucense del Año 2025
Este reconocimiento pone en valor la trayectoria de Cintia Folgueira y su extraordinaria contribución científica, así como su compromiso con la divulgación y la excelencia en la investigación biomédica en Galicia.
Calendar
COMMON SUPPORT PLATFORMS
The platforms are research support units featured by a high strategic value, equipped by cutting edge technologies and operated by highly specialised technical staff.
CALLS
All updated information on public and private competitive calls. The most convenient and safest way to send your requests.
CAREERS
Would you like to join our team? We are always looking for people with a passion for research and propelled by insatiable curiosity to join our mission of providing a better healthcare day every day. Here you can see and apply for our current vacancies.
Research Areas
ONCOLOGY
Improvement of treatments: personalised therapy and reduction of side effects.
GENETICS AND SYSTEMS BIOLOGY
Identification of genetic biomarkers of disease susceptibility and prognosis
ENDOCRINOLOGÍA, NUTRICIÓN Y METABOLISMO
The area studies obesity from different perspectives with the participation of groups from the clinical and basic fields in a synergistic way.
NEUROSCIENCES
Search for new therapeutic targets and improvement of the clinical-therapeutic management of neurological patients, mainly stroke, Alzheimer’s, Parkinson’s disease, headaches and neurological diseases caused by prions.
CARDIOVASCULAR
The general objective of the Cardiovascular Area consists of the search for new therapeutic targets and the improvement of clinical-therapeutic management.
PLATFORMS AND METODOLOGY
The area aims at providing evidence for prioritising the management of public resources, evaluating risks and identifying opportunities for improving the health of the population. From here, prioritise structural investments and action programs.
Area Leader A001 - Oncology. Lead Researcher of the group C030 - Translational Medical Oncology
Area Leader A007 - Infectology, Inflammation and Vaccines. Lead researcher of the group C020 - Genetics, Vaccines, Infections and Paedriatics (GENVIP)
Scientific Director of the IDIS - Lead Researcher of group C012 - Metabolic Disorders
Area Leader A006 - Cardiovascular. Lead Researcher of group C016 - Cardiology
Area Leader A004 - Neurosciences. Lead researcher of group C018 - Experimental Neurology of Parkinson's Disease
Area Leader A005 - Platforms and Methodology. Lead Researcher of group C015 - Research Methodology
Leader Area A003 - Endocrinology, nutrition and metabolism. Leader of group C006 - Molecular endocrinology
Area leader A002 - Genetics and Systems Biology. Lead Researcher of the group C002 - Genetics
